Onderneming ADVANZ PHARMA Corp. Limited Toronto S.E.
Aandelen
ADVZ
JE00BJVH6L55
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Steffen Wagner
CEO | Chief Executive Officer | - | 01-04-22 |
Andreas Stickler
DFI | Director of Finance/CFO | 53 | 01-01-22 |
Nick Warwick
CTO | Chief Tech/Sci/R&D Officer | - | 01-06-20 |
Karl Belk
COO | Chief Operating Officer | 56 | 01-10-15 |
Adam Peeler
IRC | Investor Relations Contact | - | 01-11-15 |
Corporate Officer/Principal | - | - | |
General Counsel | - | 01-05-22 | |
Fiona Huzarski
HRO | Human Resources Officer | - | - |
Simon Tucker
PRN | Corporate Officer/Principal | - | 01-06-18 |
Chris Britten
PRN | Corporate Officer/Principal | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Raj Shah
BRD | Director/Board Member | 55 | - |
Rainer Lenhard
BRD | Director/Board Member | - | - |
Steffen Wagner
CEO | Chief Executive Officer | - | 01-04-22 |
Andreas Stickler
DFI | Director of Finance/CFO | 53 | 01-01-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 48 913 490 | 48 854 243 ( 99,88 %) | 0 | 99,88 % |
Bedrijfsgegevens
Advanz Pharma Corp. Ltd.
Capital House 85 King William Street
EC4N 7BL, London
+44 2085 889 100
http://www.advanzpharma.comBedrijven van de groep
Naam | Categorie en sector |
---|---|
Advanz Pharma (Jersey) Ltd.
Advanz Pharma (Jersey) Ltd. Pharmaceuticals: MajorHealth Technology Part of Advanz Pharma Corp. Ltd., Advanz Pharma (Jersey) Ltd. develops pharmaceutical products and medical devices. The company is based in St. Helier, UK. |
Pharmaceuticals: Major
|
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,36% | 709 mld. | |
+30,77% | 595 mld. | |
-1,60% | 367 mld. | |
+20,07% | 334 mld. | |
+6,04% | 289 mld. | |
+14,77% | 239 mld. | |
+9,13% | 211 mld. | |
-3,97% | 203 mld. | |
+9,27% | 171 mld. |